Found: 15
Select item for more details and to access through your institution.
Use of Complementary and Alternative Therapies in Outpatients with Atopic Dermatitis from a Dermatological University Department.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Factors affecting quality of life in patients with hidradenitis suppurativa.
- Published in:
- Archives of Dermatological Research, 2020, v. 312, n. 6, p. 427, doi. 10.1007/s00403-019-02025-5
- By:
- Publication type:
- Article
Concurrent use of omalizumab and dupilumab in a 47‐year‐old woman with chronic spontaneous urticaria and atopic dermatitis.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 5, p. e173, doi. 10.1111/ijd.16009
- By:
- Publication type:
- Article
Omalizumab for atopic dermatitis: case series and a systematic review of the literature.
- Published in:
- International Journal of Dermatology, 2017, v. 56, n. 1, p. 18, doi. 10.1111/ijd.13353
- By:
- Publication type:
- Article
Certolizumab pegol for hidradenitis suppurativa: Case report and literature review.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 6, p. 1, doi. 10.1111/dth.14494
- By:
- Publication type:
- Article
Omalizumab for cholinergic urticaria: 6 months prospective study and systematic review of the literature.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 6, p. 1, doi. 10.1111/dth.14010
- By:
- Publication type:
- Article
Dupilumab for prurigo nodularis: Case series and review of the literature.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 2, p. 1, doi. 10.1111/dth.13222
- By:
- Publication type:
- Article
Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study.
- Published in:
- Clinical & Experimental Allergy, 2022, v. 52, n. 5, p. 715, doi. 10.1111/cea.14121
- By:
- Publication type:
- Article
Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease: Report and systematic literature review of effectiveness and safety.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 12, p. 2874, doi. 10.1002/ccr3.3090
- By:
- Publication type:
- Article
Immunoinflammatory Biomarkers in Serum Are Associated with Disease Severity in Atopic Dermatitis.
- Published in:
- Dermatology (10188665), 2021, v. 237, n. 4, p. 513, doi. 10.1159/000514503
- By:
- Publication type:
- Article
Events during the 3 Months Immediately Preceding Onset of Chronic Urticaria: A Questionnaire Study.
- Published in:
- Dermatology (10188665), 2021, v. 237, n. 2, p. 320, doi. 10.1159/000505514
- By:
- Publication type:
- Article
Liver enzyme levels are associated with markers of systemic inflammation, disease severity, and metabolic syndrome in patients with hidradenitis suppurativa.
- Published in:
- Health Science Reports, 2021, v. 4, n. 3, p. 1, doi. 10.1002/hsr2.360
- By:
- Publication type:
- Article
A fragment of type VI collagen alpha-6 chain is elevated in serum from patients with atopic dermatitis, psoriasis, hidradenitis suppurativa, systemic lupus erythematosus and melanoma.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28746-2
- By:
- Publication type:
- Article
Type 2 diabetes and psoriasis: links and risks.
- Published in:
- Psoriasis: Targets & Therapy, 2019, v. 9, p. 1, doi. 10.2147/PTT.S159163
- By:
- Publication type:
- Article
Determinants of disease severity among patients with atopic dermatitis: association with components of the atopic march.
- Published in:
- Archives of Dermatological Research, 2019, v. 311, n. 3, p. 173, doi. 10.1007/s00403-019-01895-z
- By:
- Publication type:
- Article